Becton, Dickinson and Company (NYSE:BDX) Given New $275.00 Price Target at Raymond James

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price target upped by stock analysts at Raymond James from $269.00 to $275.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Raymond James’ price objective points to a potential upside […]

Leave a Reply

Your email address will not be published.

Previous post Simon Quick Advisors LLC Purchases 608 Shares of ConocoPhillips (NYSE:COP)
Next post Comcast Co. (NASDAQ:CMCSA) Stock Holdings Lessened by Avaii Wealth Management LLC